Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Longtime CVS Health executive David Joyner ... elevated medical cost pressures in the Health Care Benefits segment, investors should no longer rely on the Company’s previous guidance provided ...

CVS Health appointed David Joyner president and CEO, effective Oct. 17, replacing Karen Lynch, who stepped down from the position. Mr. Joyner most recently served as executive vice president of ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Wells Fargo analyst Steve Baxter maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care. In his first earnings call following a ...